New Cannabix Breath Collection Unit (BCU)
New Cannabix Breath Collection Unit (BCU)
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cannabix Technologies (BLO) is participating in a new comprehensive multi-analysis study of human subjects under the influence of marijuana
  • The new study will work along side toxicologists and law enforcement officers in the southern United States
  • Cannabix has granted use of its Breath Collection Unit and newly developed laboratory “MS Breath Sampler” equipment to this important new research study
  • Cannabix Technologies develops marijuana breathalyzer technologies for law enforcement and the workplace
  • Cannabix Technologies Inc. (BLO) is up 7.41 per cent, trading at C$0.435 per share at 12:02 pm ET

Cannabix Technologies (BLO) is participating in a new comprehensive multi-analysis study of human subjects under the influence of marijuana.

The new study will work along side toxicologists and law enforcement officers in the southern United States. The study tests subject under the influence of marijuana alongside several conventional drug screening methods (blood, oral fluid etc.). 

Cannabix has granted use of its Breath Collection Unit and newly developed laboratory “MS Breath Sampler” equipment to this important new research study. It is building upon recent independent study results that showed excellent correlation between blood plasma THC and breath samples collected and analyzed with Cannabix equipment.

This study provides a critical launch point for Cannabix devices regarding law enforcement and toxicology audience. Breath testing for THC would allow law enforcement to quickly and practically identify recent marijuana use that aligns with the timing window of impairment, unlike other technologies such as saliva or urine.

According to the NHTSA report to congress (2017), THC in the blood drops rapidly after smoking cessation. In contrast to alcohol which metabolizes at a relatively steady rate, THC metabolizes at an exponentially declining rate. THC blood level first drops rapidly, then slowly decreases, reaching lower THC levels. After a few hours, only low or no THC can be detected in blood.

Confirmation of drug presence as quickly as possible after the time of a law enforcement stop is paramount. It increases the chance of convictions for drugged driving. Cannabix equipment can help reduce the time to confirm drug presence with easy-to-collect breath samples using breath analysis techniques that law enforcement officers are already familiar with.

Cannabix Technologies develops marijuana breathalyzer technologies for law enforcement and the workplace. It is developing drug-screening devices that will detect THC – the psychoactive component of marijuana that causes impairment using breath samples.

Cannabix Technologies Inc. (BLO) is up 7.41 per cent, trading at C$0.435 per share at 12:02 pm ET.

More From The Market Herald

" Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.

" UniDoc (CSE:UDOC) signs agreement to provide telehealth services in Kenya

UniDoc Health (UDOC) has signed a master equipment deployment and services agreement with Claron Health to provide telehealth services in Kenya.
InnoCan - Founder and CEO, Iris Bincovich.

" Innocan Pharma (CSE:INNO) approaches 100 per cent CBD bioavailability for its LPT CBD liposomal delivery platform

Innocan Pharma (INNO) has announced results from a clinical study on dogs suffering from pain.
Microbix Biosystems Inc. - Senior Vice President of Sales and Business, Phil Casselli.

" Microbix (TSX:MBX) signs QAPs supply agreement

Microbix Biosystems (MBX) has signed a purchase and supply agreement for its Quality Assurance Program (QAP) products.